Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -1.60% | -3.91% | +5.13% |
02:31pm | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
05-09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.13% | 93.41M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Wedbush Lowers Clearside Biomedical's Price Target to $6 From $9, Keeps Outperform Rating